A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy versus Placebo in Women who have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Trial Number
NCT00866697Contact Person
Status
Completed
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
AGO-AUST
ANZGOG
BGOG
DGOG
GEICO
GINECO
JGOG
KGOG
MaNGO
MITO
NSGO-CTU